Trial explores immunotherapy for opportunistic viruses in transplantation
HHV-6 reactivation predicts acute graft-versus-host disease (aGVHD)
A group from Tokyo Medical University has determined that low level HHV-6 reactivation, but not CMV, EBV or HHV-7 reactivation, is a predictive marker for the development of grade 2-4 acute GVHD after hematopoietic stem cell transplantation (HSCT).
Mixed and compartmentalized infections found in Japanese stem cell transplant patients
A team of Japanese investigators led by Tetsushi Yoshikawa found evidence of mixed infections of human herpesvirus 6B (HHV-6B) in two out of 15 stem cell transplant patients.
HHV-6 reactivation leads to acute GVHD, increased mortality
Study links HHV-6 reactivation to increasingly poor outcome following myeloablative HSCT
HHV-6 reactivation tied to increased mortality and acute GVHD in HSCT
HHV-6 detection associated with increasingly poor outcome for stem cell transplant patients.
HHV-6 Reactivation linked to complications in Allogenic Stem Cell Transplantation
Researchers have tied HHV-6 Reactivation to GVHD, seizures, pneumonia, and encephalitis in Allo-SCT patients.